Research Highlight

GLOMERULAR DISEASE

Osteopontin drives renal metabolic dysfunction in Alport syndrome

  • Subscribe to Nature Reviews Nephrology for full access:

    $199

    Subscribe

Additional access options:

Already a subscriber?  Log in  now or  Register  for online access.

References

    Original Article

    1. Ding, W. et al. Osteopontin deficiency ameliorates Alport pathology by preventing tubular metabolic deficits. JCI Insight 3, e94818 (2018)

    Download references

    Author information

    Affiliations

    1. Nature Reviews Nephrology

      • Ellen F. Carney

    Authors

    1. Search for Ellen F. Carney in:

    Corresponding author

    Correspondence to Ellen F. Carney.